BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
761 results:

  • 1. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 2. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
    Li J; Liu D; Cui M; Wei Z
    J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
    Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
    Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer.
    Shao D; Zhou H; Yu H; Zhu X
    Medicine (Baltimore); 2024 Jan; 103(3):e36891. PubMed ID: 38241595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and Clinical Outcome of ovarian cancer Patients.
    Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing.
    Keyhanian K; Han L; Howitt BE; Longacre T
    Am J Surg Pathol; 2024 Mar; 48(3):292-301. PubMed ID: 38062789
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Case of Long-Term Response to Radiotherapy for Intramedullary Spinal Cord Metastasis from ovarian cancer after Surgery].
    Sudo S; Torii A; Tomita N; Takaoka T; Horie R; Takano S; Kita N; Niwa M; Okazaki D; Imai Y; Niwa M; Nakashima Y; Osumi K; Tsuzuki Y; Kuno M; Hiwatashi A
    Gan To Kagaku Ryoho; 2023 Nov; 50(11):1219-1221. PubMed ID: 38056879
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
    Shen H; Pang Q; Gao Y; Liu H
    BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
    Lammers SWM; Geurts SME; van Hellemond IEG; Swinkels ACP; Smorenburg CH; van der Sangen MJC; Kroep JR; de Graaf H; Honkoop AH; Erdkamp FLG; de Roos WK; Linn SC; Imholz ALT; Smidt ML; Vriens IJH; Tjan-Heijnen VCG
    JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37991939
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effect of Peripheral Blood Lymphocytes on prognosis of Multiple cancers.
    Zhang X; Jing J
    Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast cancer Resection.
    Martelli G; Barretta F; Vernieri C; Folli S; Pruneri G; Segattini S; Trapani A; Carolla C; Spatti G; Miceli R; Ferraris C
    JAMA Surg; 2023 Dec; 158(12):1275-1284. PubMed ID: 37792368
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer.
    Zhan F; He L; Yu Y; Chen Q; Guo Y; Wang L
    Sci Rep; 2023 Sep; 13(1):16397. PubMed ID: 37773310
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
    Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
    Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
    Kolb S; Hoffmann I; Monjé N; Dragomir MP; Jank P; Bischoff P; Keunecke C; Pohl J; Kunze CA; Marchenko S; Schmitt WD; Kulbe H; Sers C; Sehouli J; Braicu EI; Denkert C; Darb-Esfahani S; Horst D; Sinn BV; Taube ET
    Hum Pathol; 2023 Nov; 141():158-168. PubMed ID: 37742945
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysis.
    Yang SL; Si LH; Lin RX; Gu SY; Li JH; Cui JZ; Yan CH; Farah AM; Jia Y
    Curr Probl Cancer; 2023 Dec; 47(6):101014. PubMed ID: 37718231
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of Oophorectomy on Survival and Improving Nutritional Status in ovarian Metastasis from Colorectal Adenocarcinoma.
    Miyagawa Y; Kitazawa M; Tokumaru S; Nakamura S; Koyama M; Yamamoto Y; Miyazaki S; Hondo N; Soejima Y
    Oncology; 2024; 102(2):114-121. PubMed ID: 37699374
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
    Enomoto T; Okamoto A; Kim JH; Lai CH; Wu X; Kim YM
    J Gynecol Oncol; 2023 Sep; 34(5):e86. PubMed ID: 37593814
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study.
    Liu X; Zhao Y; Jiao X; Yu Y; Li R; Zeng S; Chi J; Ma G; Huo Y; Li M; Peng Z; Liu J; Zhou Q; Zou D; Wang L; Li Q; Wang J; Yao S; Chen Y; Ma D; Hu T; Gao Q
    J Ovarian Res; 2023 Jun; 16(1):121. PubMed ID: 37370087
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
    López-González E; Rodriguez-Jiménez A; Gómez-Salgado J; Daza-Manzano C; Rojas-Luna JA; Alvarez RM
    Int J Gynaecol Obstet; 2023 Dec; 163(3):840-846. PubMed ID: 37350418
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer.
    Liu H; Zhou L; Cheng H; Wang S; Luan W; Cai E; Ye X; Zhu H; Cui H; Li Y; Chang X
    Chin Med J (Engl); 2023 Dec; 136(24):2974-2982. PubMed ID: 37284741
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.